Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review

Reuters05-15

Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review

ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. $(ZYXI)$, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Moonlight94
06-03
Moonlight94
Wow

Leave a comment

1

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2535883343?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 05:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535883343","market":"us","top_or_hot":-1,"title":"Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. <a href=\"https://laohu8.com/S/ZYXI\">$(ZYXI)$</a>, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-15 05:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. <a href=\"https://laohu8.com/S/ZYXI\">$(ZYXI)$</a>, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL5zQqM7:1","article_id":"2535883343","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535883343","pubTimestamp":1747256739,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zynex Inc. Submits FDA 510 Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","ZYXI":"Zynex, Inc."},"translate_title":"Zynex Inc.向FDA提交创新型NiCO激光脉搏血氧仪510(k)申请，标志着监管审查的重要里程碑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZYXI":0.9},"content_text":"Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    \n\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. $(ZYXI)$, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":442110806147512,"gmtCreate":1748959688039,"gmtModify":1748959690969,"author":{"id":"4112244718004092","authorId":"4112244718004092","name":"Moonlight94","avatar":"https://community-static.tradeup.com/news/94f1b0192807b224055063dcbe662d8e","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":12,"crmLevelSwitch":1,"idStr":"4112244718004092","authorIdStr":"4112244718004092"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/442110806147512","repostId":2535883343,"repostType":2,"repost":{"id":"2535883343","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1747256739,"share":"https://ttm.financial/m/news/2535883343?lang=en_US&edition=fundamental","pubTime":"2025-05-15 05:05","market":"us","language":"en","title":"Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2535883343","media":"Reuters","summary":"Zynex Inc. Submits FDA 510 Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. <a href=\"https://laohu8.com/S/ZYXI\">$(ZYXI)$</a>, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-15 05:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. <a href=\"https://laohu8.com/S/ZYXI\">$(ZYXI)$</a>, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4082":"医疗保健设备","ZYXI":"Zynex, Inc."},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL5zQqM7:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2535883343","content_text":"Zynex Inc. Submits FDA 510(k) Application for Innovative NiCO Laser Pulse Oximeter, Marking Key Milestone in Regulatory Review\n    \n\n        ENGLEWOOD, Colo., May 12, 2025 - Zynex, Inc. $(ZYXI)$, a leader in medical technology, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its NiCO™ Noninvasive CO-Oximeter device. This submission is a significant step in the company's efforts to innovate within the field of patient monitoring. The NiCO Laser Pulse Oximeter is designed to provide more reliable and accurate oxygen status information, potentially revolutionizing the pulse oximetry market, which is projected to grow from $2.8 billion today to $4.3 billion by 2027. The device aims to enhance patient care by offering real-time data on various hemoglobin species, enabling earlier detection of conditions such as hypoxia and hyperoxia.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-007779), on May 14, 2025, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"ZYXI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535883343","isCrawlerRequest":true}